Home/Pipeline/Sodium Thiosulfate Injection, USP

Sodium Thiosulfate Injection, USP

Cyanide Poisoning

ApprovedCommercial

Key Facts

Indication
Cyanide Poisoning
Phase
Approved
Status
Commercial
Company

About Hope Pharmaceuticals

Hope Pharmaceuticals is a private, commercial-stage biotech company specializing in life-saving antidotes for acute poisoning. Its flagship offering is an FDA-approved cyanide antidote kit, Nithiodote, which combines Sodium Nitrite and Sodium Thiosulfate injections. The company appears to be revenue-generating with a focused commercial product targeting hospital emergency departments, first responders, and poison control centers. Its business model is centered on the development and commercialization of essential, niche therapeutics for critical care scenarios.

View full company profile

Therapeutic Areas

Other Cyanide Poisoning Drugs

DrugCompanyPhase
Nithiodote KitsHope PharmaceuticalsApproved
Sodium Nitrite Injection, USPHope PharmaceuticalsApproved